Literature DB >> 22221836

Kidney allograft inflammation and fibrosis, causes and consequences.

M Gago1, L D Cornell, W K Kremers, M D Stegall, F G Cosio.   

Abstract

This study assessed the development of allograft interstitial fibrosis and inflammation (GIF+"i"), a histologic pattern associated with reduced graft survival. Included are 795 adults, recipients of kidney allografts from 2000 to 2006. GIF+"i" was diagnosed in surveillance and clinical biopsies that had no transplant glomerulopathy. With time, posttransplant increasing number of grafts showed GIF+"i" and these patients had reduced death-censored graft survival (HR = 4.33 (2.49-7.53), p < 0.0001). Development of GIF+"i" was related to prior acute cellular rejection (ACR), BK nephropathy (PVAN), increasing number of HLA mismatches, retransplantation and DGF. However, 46.4% of GIF+"i" cases had no history of ACR or PVAN. Anti-HLA antibodies at transplant did not relate to GIF+"i" and these patients had no increased frequency of new antibody formation posttransplant. Post-ACR biopsies showed that GIF+"i" developed more commonly after clinically and/or histologically more severe ACR. Graft inflammation persisted in 38.7 and 29.6% of grafts 2 and 12 months post-ACR. Twelve months post-ACR, 27.1% of biopsies developed moderate-severe GIF and 51.8% showed GIF and inflammation. Persistent inflammation and progressive GIF is often subclinical but may lead to graft failure. GIF+"i" can be initiated by multiple etiologies but it is often postinfectious or due to persistent cellular immune-mediated injury. © Copyright 2011 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Year:  2012        PMID: 22221836     DOI: 10.1111/j.1600-6143.2011.03911.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  24 in total

1.  Novel markers of graft outcome in a cohort of kidney transplanted patients: a cohort observational study.

Authors:  C Alfieri; A Regalia; G Moroni; D Cresseri; F Zanoni; M Ikehata; P Simonini; M P Rastaldi; G Tripepi; C Zoccali; C Chatziantoniou; Piergiorgio Messa
Journal:  J Nephrol       Date:  2019-01-10       Impact factor: 3.902

2.  Key driver genes as potential therapeutic targets in renal allograft rejection.

Authors:  Zhengzi Yi; Karen L Keung; Li Li; Min Hu; Bo Lu; Leigh Nicholson; Elvira Jimenez-Vera; Madhav C Menon; Chengguo Wei; Stephen Alexander; Barbara Murphy; Philip J O'Connell; Weijia Zhang
Journal:  JCI Insight       Date:  2020-08-06

3.  Progression of Interstitial Fibrosis during the First Year after Deceased Donor Kidney Transplantation among Patients with and without Delayed Graft Function.

Authors:  Raymond L Heilman; Maxwell L Smith; Byron H Smith; Ibrahim Qaqish; Hasan Khamash; Andrew L Singer; Bruce Kaplan; Kunam S Reddy
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-24       Impact factor: 8.237

Review 4.  Allograft rejection and tubulointerstitial fibrosis in human kidney allografts: interrogation by urinary cell mRNA profiling.

Authors:  Thangamani Muthukumar; John R Lee; Darshana M Dadhania; Ruchuang Ding; Vijay K Sharma; Joseph E Schwartz; Manikkam Suthanthiran
Journal:  Transplant Rev (Orlando)       Date:  2014-05-27       Impact factor: 3.943

5.  Pretransplant transcriptomic signature in peripheral blood predicts early acute rejection.

Authors:  Weijia Zhang; Zhengzi Yi; Chengguo Wei; Karen L Keung; Zeguo Sun; Caixia Xi; Christopher Woytovich; Samira Farouk; Lorenzo Gallon; Madhav C Menon; Ciara Magee; Nader Najafian; Milagros D Samaniego; Arjang Djamali; Stephen I Alexander; Ivy A Rosales; Rex Neal Smith; Philip J O'Connell; Robert Colvin; Paolo Cravedi; Barbara Murphy
Journal:  JCI Insight       Date:  2019-06-06

6.  Risk factors for graft loss and death among kidney transplant recipients: A competing risk analysis.

Authors:  Jessica Pinto-Ramirez; Andrea Garcia-Lopez; Sergio Salcedo-Herrera; Nasly Patino-Jaramillo; Juan Garcia-Lopez; Jefferson Barbosa-Salinas; Sergio Riveros-Enriquez; Gilma Hernandez-Herrera; Fernando Giron-Luque
Journal:  PLoS One       Date:  2022-07-14       Impact factor: 3.752

7.  Gut microbiota-dependent modulation of innate immunity and lymph node remodeling affects cardiac allograft outcomes.

Authors:  Jonathan S Bromberg; Lauren Hittle; Yanbao Xiong; Vikas Saxena; Eoghan M Smyth; Lushen Li; Tianshu Zhang; Chelsea Wagner; W Florian Fricke; Thomas Simon; Colin C Brinkman; Emmanuel F Mongodin
Journal:  JCI Insight       Date:  2018-10-04

Review 8.  Kidney Fibrosis: Origins and Interventions.

Authors:  Thomas Vanhove; Roel Goldschmeding; Dirk Kuypers
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

9.  Inflammation and Atherosclerosis Are Associated With Hypertension in Kidney Transplant Recipients.

Authors:  Maria A Azancot; Natalia Ramos; Irina B Torres; Clara García-Carro; Katheryne Romero; Eugenia Espinel; Francesc Moreso; Daniel Seron
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-08-21       Impact factor: 3.738

10.  Clinical Relevance of Corticosteroid Withdrawal on Graft Histological Lesions in Low-Immunological-Risk Kidney Transplant Patients.

Authors:  Domingo Hernández; Juana Alonso-Titos; Teresa Vázquez; Myriam León; Abelardo Caballero; María Angeles Cobo; Eugenia Sola; Verónica López; Pedro Ruiz-Esteban; Josep María Cruzado; Joana Sellarés; Francesc Moreso; Anna Manonelles; Alberto Torío; Mercedes Cabello; Juan Delgado-Burgos; Cristina Casas; Elena Gutiérrez; Cristina Jironda; Julia Kanter; Daniel Serón; Armando Torres
Journal:  J Clin Med       Date:  2021-05-07       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.